by-the-numbers-patients-lose-when-the-government-sets-prices Blog Related Topics 
Omnicell
JANUARY 10, 2023
Ted Slafsky Founder and Principal, Wexford Solutions, and Publisher and CEO, 340B Report As of publication time, eight pharmaceutical manufacturers either have stopped offering or placed significant restrictions on 340B discounts when a provider contracts with a retail or community pharmacy to dispense medicines. First, in March, U.S.
Omnicell
JANUARY 10, 2023
This will have significant implications for the 340B drug pricing program, not only for policy but also for the key players setting the agenda. This will have significant implications for the 340B drug pricing program, not only for policy but also for the key players setting the agenda. Other polls show similar trends.
Expert insights. Personalized for you.
52 
Let's personalize your content